← Leaderboards
Linda M Boxer
Stanford University
$7,394,229
Attributed
$7,394,229
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $571.5K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$7,394,229 · 6
By mechanism
R01$5,777,782 · 4
T32$1,321,522 · 1
R56$294,925 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Sylvia Katina Plevritis$44,733,712
- Ronald Levy$27,846,042
- Robert S Negrin$29,816,136
- Daniel L Rubin$10,989,812
- Harry Bernard Greenberg$91,083,131
Others in their field
Top investigators on “Neoplasm /Cancer Genetics”
- Gregory H Reaman · National Childhood Cancer Foundation$112,559,481
- Charles A Coltman · Southwest Oncology Group$46,831,444
- Samuel A Wells · Duke University$32,148,803
- David Sidransky · Johns Hopkins University$27,906,864
- Brian E Henderson · University Of Southern California$27,493,155
- Bruce W Stillman · Cold Spring Harbor Laboratory$22,532,365
Research focus
Neoplasm /Cancer GeneticsGenetic TranscriptionChromosome TranslocationLymphomaProtooncogeneLaboratory MouseClinical ResearchNeoplastic TransformationImmunoglobulin GenesGenetic Promoter ElementHuman SubjectTranscription FactorB LymphocyteCell LineCancer CellBcl2 GeneCamp Response Element Binding ProteinBurkitt'S LymphomaGene ExpressionGenetic RegulationCodeB-LymphocytesComplexChromosome Structures
Grant awards (31)
Activation of BCL-2 in Hematologic Malignancies$281,785
R01 · FY2012 · CA · contact PI
Activation of BCL-2 in Hematologic Malignancies$281,785
R01 · FY2011 · CA · contact PI
Activation of BCL-2 in Hematologic Malignancies$290,500
R01 · FY2010 · CA · contact PI
Training Program in Investigative Hematology$99,145
T32 · FY2010 · HL · contact PI
Activation of BCL-2 in Hematologic Malignancies$290,500
R01 · FY2009 · CA · contact PI
Training Program in Investigative Hematology$115,036
T32 · FY2009 · HL · contact PI
Activation of BCL-2 in Hematologic Malignancies$290,500
R01 · FY2008 · CA · contact PI
Training Program in Investigative Hematology$262,827
T32 · FY2008 · HL · contact PI
Activation of BCL-2 in Hematologic Malgnancies$294,925
R56 · FY2007 · CA · contact PI
Training Program in Investigative Hematology$262,827
T32 · FY2007 · HL · contact PI
Training Program in Investigative Hematology$267,685
T32 · FY2006 · HL · contact PI
Activation of BCL-2 in Hematologic Malignancies$267,388
R01 · FY2006 · CA · contact PI
Activation of BCL-2 in Hematologic Malignancies$273,822
R01 · FY2005 · CA
CONTROL OF C-MYC TRANSCRIPTION IN HIGH GRADE LYMPHOMA$248,111
R01 · FY2005 · CA
TRAINING PROGRAM IN INVESTIGATIVE HEMATOLOGY$49,539
T32 · FY2005 · HL
Activation of BCL-2 in Hematologic Malignancies$273,823
R01 · FY2004 · CA
Training Program in Investigative Hematology$264,463
T32 · FY2004 · HL
CONTROL OF C-MYC TRANSCRIPTION IN HIGH GRADE LYMPHOMA$248,036
R01 · FY2004 · CA
Molecular Studies of Human All$226,000
R01 · FY2004 · CA
Activation of BCL-2 in Hematologic Malignancies$273,822
R01 · FY2003 · CA
CONTROL OF C-MYC TRANSCRIPTION IN HIGH GRADE LYMPHOMA$247,963
R01 · FY2003 · CA
Molecular Studies of Human All$225,100
R01 · FY2003 · CA
Activation of BCL-2 in Hematologic Malignancies$272,694
R01 · FY2002 · CA
CONTROL OF C-MYC TRANSCRIPTION IN HIGH GRADE LYMPHOMA$247,893
R01 · FY2002 · CA
Molecular Studies of Human All$223,219
R01 · FY2002 · CA
CONTROL OF MYC TRANSCRIPTION IN HIGH GRADE LYMPHOMA$245,748
R01 · FY2001 · CA
ACTIVATION OF BCL 2 IN HEMATOLOGIC MALIGNANCIES$230,166
R01 · FY2001 · CA
Molecular Studies of Human All$223,300
R01 · FY2001 · CA
ACTIVATION OF BCL 2 IN HEMATOLOGIC MALIGNANCIES$227,407
R01 · FY2000 · CA
REGULATION OF EXPRESSION OF C-MYB IN LEUKEMIAS$195,466
R01 · FY2000 · CA
CONTROL OF C MYC TRANSCRIPTION IN HIGH GRADE LYMPHOMAS$192,754
R01 · FY2000 · CA